Delivery Order SPE2DB24D2205-SPE2DB25FEBNX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL injectable medication. The contract, valued at $17,708.07, represents a firm fixed price delivery order with an ultimate completion date of July 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication, valued at $24,255.06. The contract, which was competitively awarded with no set-aside designation, was awarded on August 5, 2025, with a completion date of August 6, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, and is priced on a firm fixed-price basis. This delivery order is...
- The Defense Logistics Agency awarded a $31,772.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 17, 2025. This competitive award, issued on July 16, 2025, carries a firm fixed price and involves no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution and pharmaceutical supply...
- The Defense Logistics Agency has awarded a delivery order valued at $45,125.00 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml injectable medication. This competitive, non-set-aside award was executed on November 4, 2025, with an ultimate completion date of November 5, 2025. The contract utilizes firm fixed price terms for this pharmaceutical delivery, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $23,523.84 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL injectable medication. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025, and represents a single delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication in a 3 mL vial quantity, with a contract ceiling value of $4,115.08. The award, issued on November 7, 2025, represents a firm fixed price delivery order with an ultimate completion date of November 10, 2025. This non-set-aside competitive award will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania location, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with a ceiling value of $3,494.97. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order issued under a larger federal contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication with a ceiling value of $26,288.04. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials under a firm fixed-price contract valued at $1,879.98. The award was made on October 28, 2025, with an ultimate completion date of October 29, 2025, and was competitively awarded with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $9,893.77 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) injectable medication. The contract is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and was awarded on November 5, 2025, with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEBNXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication with a ceiling value of $31,171.16 under a firm fixed price contract type. The award was made on April 28, 2025, with an ultimate completion date of April 29, 2025, and no set-aside designation was used in the procurement. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a task against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen regularly fulfills competitively awarded delivery orders for brand-name and generic medications, including specialty pharmaceuticals and diabetes treatments like Ozempic, supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.2k | 4/28/25 |